10.45Open10.45Pre Close0 Volume1 Open Interest12.50Strike Price0.00Turnover182.77%IV3.47%PremiumJan 17, 2025Expiry Date9.68Intrinsic Value100Multiplier23DDays to Expiry0.77Extrinsic Value100Contract SizeAmericanOptions Type0.9302Delta0.0131Gamma2.20Leverage Ratio-0.0305Theta0.0067Rho2.04Eff Leverage0.0075Vega
Life Time Stock Discussion
Select biotech/pharma names showing strength following ESMO:
$Clovis Oncology (CLVS.US)$ +11.3%, $Cardiff Oncology (CRDF.US)$ +9%, $Immatics (IMTX.US)$ +8.3%, $IDEAYA Biosciences (IDYA.US)$ +8%, $Lyra Therapeutics (LYRA.US)$ +5.7%, $POINT Biopharma (PNT.US)$ +5.7%, $Edgewise Therapeutics (EWTX.US)$ +4.7%, $Concert Pharmaceuticals (CNCE.US)$ +3.6%, $Deciphera Pharmaceuticals (DCPH.US)$ +3.2%, $Veracyte (VCYT.US)$ +2.6%, $SpringWorks Therapeutics (SWTX.US)$ +2.3%, ...
No comment yet